To further understand the potential biological pathways involving SLC35A2 in colorectal cancer, we utilized gene set enrichment analysis (GSEA) and explored the relationship between SLC35A2 expression and drug sensitivity by analyzing data from Cancer Cell Line Encyclopedia (CCLE) and TCGA. This evidence concerns the gene SLC35A2 and colorectal cancer.